163 related articles for article (PubMed ID: 16495932)
1. Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy.
Deans DA; Wigmore SJ; Gilmour H; Tisdale MJ; Fearon KC; Ross JA
Br J Cancer; 2006 Mar; 94(5):731-6. PubMed ID: 16495932
[TBL] [Abstract][Full Text] [Related]
2. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
[TBL] [Abstract][Full Text] [Related]
3. Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.
Deans DA; Wigmore SJ; Gilmour H; Tisdale MJ; Fearon KC; Ross JA
Br J Cancer; 2008 Jan; 98(1):243. PubMed ID: 18087288
[No Abstract] [Full Text] [Related]
4. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss.
Cabal-Manzano R; Bhargava P; Torres-Duarte A; Marshall J; Bhargava P; Wainer IW
Br J Cancer; 2001 Jun; 84(12):1599-601. PubMed ID: 11401311
[TBL] [Abstract][Full Text] [Related]
6. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).
Todorov PT; Field WN; Tisdale MJ
Br J Cancer; 1999 Aug; 80(11):1734-7. PubMed ID: 10468289
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor.
Wigmore SJ; Todorov PT; Barber MD; Ross JA; Tisdale MJ; Fearon KC
Br J Surg; 2000 Jan; 87(1):53-8. PubMed ID: 10606911
[TBL] [Abstract][Full Text] [Related]
8. [Proteolysis induce factor in the digestive systematic cancer cachexia patients: its expression and role in cancer cachexia].
Han YS; Zhuang QL; Wu GH
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Dec; 15(12):1287-90. PubMed ID: 23268279
[TBL] [Abstract][Full Text] [Related]
9. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.
Hussey HJ; Todorov PT; Field WN; Inagaki N; Tanaka Y; Ishitsuka H; Tisdale MJ
Br J Cancer; 2000 Jul; 83(1):56-62. PubMed ID: 10883668
[TBL] [Abstract][Full Text] [Related]
10. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.
Deans DA; Wigmore SJ; Gilmour H; Paterson-Brown S; Ross JA; Fearon KC
Br J Cancer; 2006 Dec; 95(11):1568-75. PubMed ID: 17088911
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers.
Angelescu C; Burada F; Ioana M; Angelescu R; Moraru E; Riza A; Marchian S; Mixich F; Cruce M; Săftoiu A
Clin Transl Oncol; 2013 Apr; 15(4):313-20. PubMed ID: 22872519
[TBL] [Abstract][Full Text] [Related]
12. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
Wallander K; Eisfeldt J; Lindblad M; Nilsson D; Billiau K; Foroughi H; Nordenskjöld M; Liedén A; Tham E
PLoS One; 2021; 16(2):e0245488. PubMed ID: 33539436
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).
Mirza KA; Wyke SM; Tisdale MJ
Br J Cancer; 2011 Jun; 105(1):83-8. PubMed ID: 21673682
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.
Skipworth RJ; Stewart GD; Bhana M; Christie J; Sturgeon CM; Guttridge DC; Cronshaw AD; Fearon KC; Ross JA
Int J Oncol; 2010 Apr; 36(4):973-82. PubMed ID: 20198343
[TBL] [Abstract][Full Text] [Related]
15. Catabolic mediators of cancer cachexia.
Tisdale MJ
Curr Opin Support Palliat Care; 2008 Dec; 2(4):256-61. PubMed ID: 19069310
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinicopathologic significance of proteolysis-inducing factor in non-small-cell lung cancer: an immunohistochemical analysis.
Wang Q; Lu JB; Wu B; Hao LY
Clin Lung Cancer; 2010 Sep; 11(5):346-51. PubMed ID: 20837461
[TBL] [Abstract][Full Text] [Related]
17. mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.
Baren JP; Stewart GD; Stokes A; Gray K; Pennington CJ; O'Neill R; Deans DA; Paterson-Brown S; Riddick AC; Edwards DR; Fearon KC; Ross JA; Skipworth RJ
Br J Cancer; 2012 Jun; 107(1):143-9. PubMed ID: 22677901
[TBL] [Abstract][Full Text] [Related]
18. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.
Fareed KR; Al-Attar A; Soomro IN; Kaye PV; Patel J; Lobo DN; Parsons SL; Madhusudan S
Br J Cancer; 2010 May; 102(11):1600-7. PubMed ID: 20461087
[TBL] [Abstract][Full Text] [Related]
19. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
Lorite MJ; Smith HJ; Arnold JA; Morris A; Thompson MG; Tisdale MJ
Br J Cancer; 2001 Jul; 85(2):297-302. PubMed ID: 11461093
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.
De Cobelli F; Giganti F; Orsenigo E; Cellina M; Esposito A; Agostini G; Albarello L; Mazza E; Ambrosi A; Socci C; Staudacher C; Del Maschio A
Eur Radiol; 2013 Aug; 23(8):2165-74. PubMed ID: 23588582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
